Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    Why did this record match?
    Applicant Name (Manufacturer) :

    Corin Ltd.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The BiPolar-i is intended for use in the following indications: Non-inflammatory degencrative joint disease including osteoarthritis and avascular necrosis in which the acetabulum does not require replacement, Treatment of non-union, femoral neck and trochanteric fractures of the proximal femur, Revision of failed partial hip replacements in which the acetabulum does not require replacement. The BiPolar-i is indicated for cementless use only.

    The Trinity Acetabular System is indicated for use in non-intlammatory degenerative joint disease including osteoarthritis and avascular necrosis, rheumatoid arthritis, correctional deformity, developmental dysplasia of the hip (DDH) or congenital dysplasia of the hip (CDH). The Trinity Acctabular System is intended for cementless, single use only.

    The indications for the Corin MctaFixM Hip Stem as a total hip arthroplasty, and when used in combination with a Corin hemi arthroplasty head, as a hip hemi-arthroplasty, include: Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis, Rheumatoid arthritis, Correction of functional deformity, Treatment of non-union and femoral neck fractures, Developmental dysplasia of the hip (DDH) and congenital dysplasia of the hip (CDH). The Corin MetaFixTM Hip Stem is indicated for cementless use only.

    The indications for the MiniHip Stem as a total hip arthroplasty include: Non-inflammatory degenerative joint disease including osteoarthriis and avascular necrosis Rheumatoid arthritis Correction of functional deformity. Developmental dysplasia of the hip (DDH) and congenital dysplasia of the hiniHip Stem is indicated for cementless use only.

    The indications for the TrinityTM Accabular System as a total hip arthroplasty include: Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis, Rheunatoid arthritis, Correction of functional deformity, Developmental dysplasia of the hip (DDH), and congenital dysplasia of the hip (CDH). The Trinity Acctabular System is intended for cementless, single use only.

    The Trinity Dual Mobility System is intended for use in the following indications: 1. Non-inflammatory degenerative joint disease, including osteoarthritis & avascular necrosis 2. Rheumatoid Arthritis 3. Correction of functional deformity 4. Revision of previously failed total hip arthroplasty 5. Patients at increased risk of dislocation 6. Developmental dysplasia of the hip (DDH). The Trinity TM Dual Mobility System is indicated for cementless use only.

    The indications for the Corin Trinity™ PLUS Accabular Shell as a total hip arthroplasty include: Non-inflammalory degenerative joint disease including ostoarthritis and avascular necrosis. Rheumatoid arthritis. Correction of functional deformity, Revision of previously failed total hip arthroplasty, Developmental dysplasia of the hip (DDH). The Trinity TM PLUS Acctabular Shell is indicated for cement less use only.

    The MobiliT Cup, for cemented and cementless use, are indicated for primary replacement of the hip joint: - In degenerative pathologies: primary, secondary or post-traumatic osteoarthritis, rheumatoid arthritis - For patients who have a high risk of dislocation - In cases of necrosis of the femoral head - In cases of fracture of the neck of the femur - In cases of congenital luxation. The MobiliT Cup, for cemented and cementless use, are indicated for revision when the bone tissue remains sufficient after the removal of the previous acetabular cup. The cementless MobiliT standard Cup, with flanges or with flanges and hook are indicated for cementless use only. The cemented MobiliT Cup is indicated for cemented use only.

    The Apex Hip System Bipolar Head is intended for use in combination with an Apex Hip System for uncemented primary or revision hemiarthroplasty of the hip. This prosthesis may be used for the following conditions, as appropriate: Femoral neck and trochanteric fractures of the proximal femur. Osteonecrosis of the femoral head, Revision procedures where other devices or treatments for these indications have failed.

    The OMNI Hip system Ceramic Femoral Heads are intended for use in combination with the OMNI Hip System Stems as the femoral component in total hip replacement procedures. This ceramic head is intended to articulate with the OMNI Interface Acctabular System or bipolar component. This prosthesis is intended for single use may be used for the following conditions, as appropriate: Non-inflammatory degenerative joint disease, including osteoarthritis and avascular necrosis; Rheumatoid arthritis; Correction of functional deformity; Congenital dislocation; Revision procedures where other treatments or devices have failed; Femoral neck and trochanteric fiactures of the proximal femur.

    The indications for use of the OMNI Modular Hip Stems in hip arthroplasty include the following conditions, as appropriate: Non-inflammatory degenerative joint disease, including osteoarthritis and avascular necrosis; Rheumatoid arthritis: Correction of functional deformity; Congenital dislocation: Revision procedures where other treatments or devices have failed; Femoral neck and trochanteric fractures of the proximal femur. The OMNI Modular Hip stems are indicated for cementless use only and single use implantation.

    The indications for use of the OMNI Modular Hip Stems in hip arthroplasty include the following conditions, as appropriate: Non-inflammatory degenerative joint disease, including osteoarthritis and avascular necrosis; Rheumatoid arthritis: Correction of functional deformity; Congenital dislocation: Revision procedures where other treatments or devices have failed; Femoral neck and trochanteric fractures of the proximal femur. The OMNI Modular Hip stems are indicated for cementless use only and single use implantation.

    The Revival Modular Revision Hip Stem is indicated in revision surgery of femoral components, following failure of primary cemented or un-cemented prosthesis. The REVIVAL™ Hip Stem 100mm distal component is also indicated in primary total hip arthroplasty. The indications for the Revival TM Modular Revision Hip Stem include: Non-inflammatory degenerative joint disease including primary and secondary osteoarthritis. Rheumatoid arthritis, Correction of functional deformity, Treatment of non-union and femoral neck fractment of traumatic dislocations of the hip, Failures of osteotomy, Treatment of arthrodesis. The Revival ™ Revision Hip Stem is indicated for cementless, single use only.

    TaperFirM Hip Stem is indicated for the relief of pain and restoration following the effects of femoral neck fracture, osteo, theumatory arthritis, post- traumatic disease effects, avascular necrosis and total hip revision. The Taper it Hip Stem is indicated for hemi-arthroplasty when used in combination with Corin hemiarthroplasty femoral heads. The TaperFitTM Hip Stem is indicated for cemented, single use only.

    The indications for use of the K 1 Hip arthroplasty include the following conditions, as appropriate: Noninflammatory degenerative joint disease, including osteoarthritis and avascular necrosis: Rheumatoid arthritis: Correction of functional deformity: Congenital disfocation: Revision procedures where other treatments or devices have failed; Femoral neck and trochanteric fractures of the proximal femur. The K 1 Hip Stem is indicated for cementless use only and single use implantation.

    The indications for the TriFit CF Hip Stem as a total hip arthroplasty and as a hip hemiarthroplasty include: Noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis, Rheumatoid arthritis, Correction of functional deformity, Treatment of non-union and femoral neck fractures, Developmental Dysplasia of the Hip (DDH), Previously failed hip surgery. The Trifit CF Hip Stem is indicated for cementless use only.

    The indications for the Corin TriFit TSTM Hip atthroplasty, and when used in combination with a Corin hemi arthroplasty head, as a hip hemi-arthroplasty, include: Non-inflammatory degenerative joint disease including osteoadhritis and avascular necrosis, Rheumatoid arthritis, Correction of functional deformity, Treatment of non-union, femoral neck and trochanteric fractures of the proximal femur, Developmental dysplasia of the hip (DDH) or congenital dysplasia of the hip (CDH). The Tril'it TS Hip is intended for cementless use only.

    Device Description

    The subject and predicate devices are one in the same and are comprised of several legally marketed Corin Ltd. hip products, which include OMNIIfe Sciences and Apex Surgical hip products. The subject devices include acetabular cups and liners, bone fixation screws, screw hole occluders, cemented and cementless femoral hip stems for primary and revision hip arthroplasty, fixation screws, modular necks, CoCrMo alloy and ceramic femoral heads, dual mobility acetabular systems, and bipolar heads. The purpose of this 510(k) is to notify the FDA of Corin's engineering assessment of the cross-compatibility of the subject devices, identification of conflicts, and updates to the product labeling. The subject hip devices components are manufactured from a variety of materials which include cobalt-chromium-molybdenum alloy, stainless steel alloy, unalloyed titanium, calcium phosphate (Bonit™ coating) Alumina Matrix Composite ceramic (Biolox Delta), and ultrahigh molecular weight polyethylene (UHMWPE), all of which conform to ASTM or ISO standards, or internal standards. The subject femoral hip stems and heads possess the same 12/14 taper design and reference system for determining head and neck offsets.

    AI/ML Overview

    I am sorry, but the provided text does not contain information about the acceptance criteria and study proving device performance as typically seen in a medical device submission beyond general statements of substantial equivalence. The document is a 510(k) summary for hip replacement components, primarily focusing on cross-compatibility of various existing devices.

    The text outlines:

    • Device identification and manufacturer information.
    • List of numerous predicate devices.
    • Detailed descriptions of the indications for use for many hip components (e.g., Corin BiPolar-i, Trinity™ Acetabular System, MetaFix™ Hip, MiniHip™, Trinity™ Dual Mobility, MobiliT™ Cup, OMNI Bipolar Head, OMNI Delta Ceramic Femoral Head, OMNI MOD Hip System, OMNI K1/K2 Hip Systems, Revival™ Modular Hip Stem, TaperFit™, TriFit™ CF/TS Hip). These indications primarily relate to non-inflammatory degenerative joint disease, rheumatoid arthritis, correction of functional deformity, avascular necrosis, fractures, and revision surgeries.
    • A "Performance Data" section which describes the types of engineering analyses and bench testing performed to establish cross-compatibility (e.g., ceramic head burst testing, head pull-off, fretting-corrosion, impingement testing, range of motion assessment, comparison of taper geometries, fatigue strength assessment, and contact stress/wear potential).

    However, it does not provide:

    1. A specific table of acceptance criteria and reported device performance for the types of tests mentioned (e.g., what burst pressure was required vs. achieved). It only lists the types of tests done.
    2. Sample sizes used for test sets or data provenance.
    3. Number of experts and their qualifications for establishing ground truth (as this pertains to clinical studies, which are not detailed here for performance).
    4. Adjudication method.
    5. Multi-reader multi-case (MRMC) comparative effectiveness study information.
    6. Standalone algorithm performance (as this is not an AI/algorithm-driven device).
    7. Type of ground truth used (again, this is not a diagnostic device with "ground truth" in the typical sense).
    8. Sample size for training set.
    9. How ground truth for the training set was established.

    The document's purpose is to demonstrate substantial equivalence of a range of hip components, including their cross-compatibility when used together. The "performance data" refers to the engineering and bench testing conducted to ensure this compatibility rather than clinical performance against specific metrics as one would find for a diagnostic or AI-driven device.

    Ask a Question

    Ask a specific question about this device

    K Number
    K200888
    Manufacturer
    Date Cleared
    2020-06-27

    (85 days)

    Product Code
    Regulation Number
    882.4560
    Reference & Predicate Devices
    Why did this record match?
    Applicant Name (Manufacturer) :

    Corin Ltd.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The OMNIBotics Knee System is indicated for stereotaxic surgery to aid the surgeon in locating and aligning endoprostheses with these anatomical structures during Total Knee Arthroplasty. The BalanceBot™ is indicated as a tool for adjustment of soft tissue and the femoral implant to reduce instability from flexion gap asymmetry. The OMNIBotics Knee System supports OMNI Apex Knee™ implants and CORIN Unity Knee™ implants.

    Device Description

    The OMNIBotics® Knee system is a computer-assisted navigation system with a motorized bone cutting quide that is used by surqeons and operating room (OR) staff to assist in performing stereotaxic total knee arthroplasty (TKA). The OMNIBotics® Knee System consists of the OMNIBotics® Station, ART Knee Application software, the OMNIBot cutting quide for quiding femoral bone resections, the BalanceBot defined as an active (motorized) knee spacer and ligament tensioning device, and the OMNIBotics™ Tracker Kit which is comprised of single-use reflective markers that are fixed onto the associated instruments that provide a frame of reference for tracking by the 3D optical optoelectronic localizer.

    The OMNIBotics® Station includes the 3D optoelectronic localizer mounted on an articulated arm, a laptop hosting the ART Knee Software and equipped with a touchscreen, an external LCD monitor and a three-button footswitch as a means for the user to interact with the system. The power supply and communication hardware required for the camera, the laptop, the OMNIBot, and BalanceBot are contained within a single enclosure, the control box, located at the base of the OMNIBotics® Station.

    The OMNIBotics® Knee System was originally cleared for use with OMNI Apex Knee™ System implants in K163338. This 510(k) notification demonstrates substantial equivalence of the OMNIBotics® Knee System for use with Corin Unity™ Total Knee System implants.

    AI/ML Overview

    Acceptance Criteria and Study for OMNIBotics® Knee System

    The OMNIBotics® Knee System, when used with Corin Unity knee implants, underwent performance testing and process validations to demonstrate substantial equivalence to its predicate device (OMNIBotics® Knee System, K163338).

    1. Acceptance Criteria and Reported Device Performance

    Acceptance Criteria CategorySpecific CriteriaReported Device Performance
    User Requirements & UsabilityDevice meets established user requirements and is usable."The results of the cadaver evaluation demonstrated that the subject device met the established criteria for user requirements, usability..."
    Accuracy of Bone ResectionsBone resections performed using the device are accurate."...accuracy of bone resections..." (Met established criteria)
    Accuracy of Implant PositionImplant positioning achieved with the device is accurate."...accuracy of implant position..." (Met established criteria)
    Magnitude of GapsAchieves appropriate magnitudes of gaps."...magnitude of gaps..." (Met established criteria)
    Joint StabilityContributes to stable joint outcomes."...and joint stability." (Met established criteria)
    Precision, Accuracy, Usability of Reflective MarkersReflective markers/marker arrays demonstrate acceptable precision, accuracy, and usability.Demonstrated through "Simulated use and validation testing".
    SterilityOMNIBotics® Tracker Kit is sterile.Validated for a sterilization dose of 25 kGy of gamma radiation according to the VD max method NF EN ISO 11137-2: 2015.
    Endotoxin LevelsEndotoxin levels of single-use reflective markers are within accepted limits."The endotoxin levels for the markers were determined to be well within the minimum acceptance criteria" (Tested per ANSI/AAMI ST72. 5.2).
    BiocompatibilitySingle-use reflective markers are non-cytotoxic."The single use markers were determined to be non-cytotoxic per ISO 10993-5."

    2. Sample Size for Test Set and Data Provenance

    • Sample Size: Ten (10) cadaver surgeries.
    • Data Provenance: Retrospective, using cadaveric subjects. The specific country of origin is not mentioned, but the manufacturer is based in the USA (Corin Ltd., Raynham, MA) and the submitter in Canada (BioVera, Inc., Quebec).

    3. Number of Experts Used to Establish Ground Truth and Qualifications

    • Number of Experts: Four (4) surgeons.
    • Qualifications: The document describes them as "Surgeon-user," implying they are practicing surgeons experienced in Total Knee Arthroplasty. No further specific details (e.g., years of experience, sub-specialty) are provided.

    4. Adjudication Method for the Test Set

    The document does not explicitly state an adjudication method (e.g., 2+1, 3+1). It reports that the evaluation "demonstrated that the subject device met the established criteria for user requirements, usability, accuracy...". This suggests a consensus or direct assessment against pre-defined criteria by the performing surgeons, rather than a separate adjudication process involving independent reviewers to resolve discrepancies.

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

    No Multi-Reader Multi-Case (MRMC) comparative effectiveness study was mentioned where human readers' performance with and without AI assistance was evaluated. The study focused on validating the device's technical performance and usability, rather than comparing human reader performance.

    6. Standalone Performance Study (Algorithm Only)

    The study described is not a standalone (algorithm only) performance study. The evaluation involved "surgeon-user verification studies," meaning human surgeons interacted with and utilized the device during the cadaver surgeries. The OMNIBotics® Knee System is a computer-assisted navigation system and cutting guide designed to aid surgeons; therefore, its performance is inherently linked to human interaction.

    7. Type of Ground Truth Used

    The ground truth was established through direct measurement and assessment by the participating surgeons during the cadaver surgeries. This includes:

    • Expert Assessment: Surgeons directly evaluated user requirements, usability, joint stability.
    • Measurement-Based Assessment: Accuracy of bone resections, implant position, and magnitudes of gaps would have been determined through intraoperative measurements and post-resection/implantation evaluation, likely against predetermined surgical plans or anatomical landmarks.
    • Laboratory Testing: For sterility, endotoxin levels, and biocompatibility of the reflective markers, specific laboratory tests (e.g., gamma radiation validation, ANSI/AAMI ST72. 5.2, ISO 10993-5) were used to establish ground truth.

    8. Sample Size for the Training Set

    The document does not mention a separate "training set" for the OMNIBotics® Knee System. This device is a navigation and cutting guide system (hardware and software), not an AI model that learns from data in the traditional sense of machine learning. The "ART Knee Application software" is part of the system, but the document does not describe it as having undergone an iterative training process with a dedicated training dataset in the context of this 510(k) submission. The validation primarily focused on the system's performance with the new implant system and revised components.

    9. How the Ground Truth for the Training Set Was Established

    As no dedicated training set is explicitly mentioned or seems applicable in the context of this device's validation described in the 510(k) summary, this question is not directly addressed by the provided text. The device's underlying algorithms and functionalities would have been developed and verified internally during its engineering and design phases, likely using various forms of testing and pre-clinical data, but these are not delineated as a "training set" in this regulatory submission.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1